top of page

VOLUNTEER FOR RESEARCH

tincture icon.png

Cannabidiol (CBD) for Anxiety

Clinical Trial

BAcKGROUND

This project is an FDA-approved clinical trial of a whole plant-derived, high-CBD sublingual tincture for the treatment of anxiety.

STUDY DETAILS

Participants are assessed at baseline and weekly for 4 weeks of treatment. The primary outcome measures of the study are clinical state measures related to anxiety. Additionally, participants will complete measures related to quality of life, sleep, and activity levels, and cognitive testing.

RECRUITMENT INFORMATION

Individuals with moderate to severe anxiety who are interested in using a high-CBD product may be eligible.

This study is currently closed to enrollment - data analysis underway.

bottom of page